SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DECODE GENETICS-*DCGN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (139)8/27/2004 10:04:08 AM
From: tom pope  Read Replies (2) of 313
 
Looks like you made a good buy, Nigel:

09:33 ET DCGN defended at Piper 5.22 -1.08: Piper Jaffray comments on PricewaterhouseCoopers resigning as deCODE's (DCGN) independent registered public accounting firm. There were no disagreements with PwC on any matter of accounting. However Piper points to an interesting comment: "PwC makes no comment whatsoever regarding...(that) the resignation of PwC was neither approved nor recommended by deCODE's Audit Committee." The firm believes this contradiction may indicate that the relationship simply deteriorated.... Nevertheless, the firm views this as an opportunity to buy the stock on weakness ahead of the DG-031 Phase IIa data in October
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext